lung: Miracle pill can keep lung cancer at bay: Report

The treatment developed by the pharmaceutical group AstraZeneca is called osimertinib and is marketed under the name Tagrisso.

Related Keywords

United States ,Chicago ,Illinois ,American ,Nathan Pennell ,Roy Herbst ,American Society For Clinical Oncology ,Cleveland Clinic Foundation ,Yale University ,Astrazeneca ,American Society ,Clinical Oncology ,Economic Times News App ,Daily Market Updates ,Live Business ,Lung ,Tagrisso ,Pennell ,Egfr ,